Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation

Description

This study is designed to evaluate the effectiveness of endovascular embolization of middle meningeal artery following evacuation of subdural hematomas (SDHs) to assess rate of recurrence. The historical standard for treatment of subdural hematomas has been surgical evacuation through burr holes or craniotomies. Many of these patients are elderly patients who are high risk surgical candidates. A major concern is SDH recurrence. Recurrences require frequent imaging, and will lead to increased length of hospital stay, increased morbidity,and re-operations. There are increasing number of reports that suggest that a less invasive approach such as endovascular embolization of the middle meningeal artery using standard endovascular materials and techniques may reduce the risk of recurrence. The reported outcomes in the current literature have been very positive when endovascular embolization has been used without surgery or as an adjuvant to surgery. However, there have been no studies directly comparing endovascular embolization following surgical evacuation to assess if this technique can actually reduce the complications of SDHs listed above. The investigators propose to study this treatment process by randomly assigning patients who have undergone surgical evacuation of SDHs into a control and treatment group. The control group will receive standard surgical evacuation of the hematoma. The study group will receive surgical evacuation followed by endovascular embolization.

Conditions

Chronic SDH and the Efficacy of Embolization

Study Overview

Study Details

Study overview

This study is designed to evaluate the effectiveness of endovascular embolization of middle meningeal artery following evacuation of subdural hematomas (SDHs) to assess rate of recurrence. The historical standard for treatment of subdural hematomas has been surgical evacuation through burr holes or craniotomies. Many of these patients are elderly patients who are high risk surgical candidates. A major concern is SDH recurrence. Recurrences require frequent imaging, and will lead to increased length of hospital stay, increased morbidity,and re-operations. There are increasing number of reports that suggest that a less invasive approach such as endovascular embolization of the middle meningeal artery using standard endovascular materials and techniques may reduce the risk of recurrence. The reported outcomes in the current literature have been very positive when endovascular embolization has been used without surgery or as an adjuvant to surgery. However, there have been no studies directly comparing endovascular embolization following surgical evacuation to assess if this technique can actually reduce the complications of SDHs listed above. The investigators propose to study this treatment process by randomly assigning patients who have undergone surgical evacuation of SDHs into a control and treatment group. The control group will receive standard surgical evacuation of the hematoma. The study group will receive surgical evacuation followed by endovascular embolization.

Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation

Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation

Condition
Chronic SDH and the Efficacy of Embolization
Intervention / Treatment

-

Contacts and Locations

Augusta

Augusta University, Augusta, Georgia, United States, 30912

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients 18-90 with chronic SDH
  • * Patients that require surgical evacuation of SDH following assessment by a neurosurgeon
  • * Glasgow Coma Scale (GCS) \>6
  • * Modified Rankin Scale (mRs) \<5
  • * Patients \< 18 or \>90 years of age
  • * Pregnancy
  • * Patients with extensive multisystem trauma requiring multidisciplinary surgical interventions
  • * Chronic renal insufficiency with creatinine \>1.8
  • * GCS \<6
  • * mRs \>4
  • * Genetic bleeding disorder
  • * Liver failure
  • * Coagulopathy
  • * Patients unable to consent who do not have an LAR available

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Augusta University,

Fernando L. Vale, M.D., PRINCIPAL_INVESTIGATOR, Medical College of Georgia-Augusta University

Study Record Dates

2024-06